Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
112.08
+1.68 (1.52%)
Jul 14, 2026, 4:00 PM EDT - Market closed
Kymera Therapeutics Market Cap
Kymera Therapeutics has a market cap or net worth of $9.22 billion as of July 14, 2026. Its market cap has increased by 197.82% in one year.
Market Cap
9.22B
Enterprise Value
7.75B
1-Year Change
197.82%
Ranking
Category
Stock Price
$112.08
Market Cap Chart
Since the IPO on August 21, 2020, Kymera Therapeutics's market cap has increased from $834.48M to $9.22B, an increase of 1,004.81%. That is a compound annual growth rate of 50.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 9.22B | 48.11% |
| Dec 31, 2025 | 6.22B | 138.91% |
| Dec 31, 2024 | 2.61B | 84.43% |
| Dec 29, 2023 | 1.41B | 3.16% |
| Dec 30, 2022 | 1.37B | -57.98% |
| Dec 31, 2021 | 3.26B | 18.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 21, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Apogee Therapeutics | 10.02B |
| Nuvalent | 9.83B |
| Corcept Therapeutics | 9.57B |
| Ionis Pharmaceuticals | 9.38B |
| Halozyme Therapeutics | 8.88B |
| Crinetics Pharmaceuticals | 8.82B |
| Praxis Precision Medicines | 8.81B |
| ImmunityBio | 8.43B |